3+3 model

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

3+3 model

Apr 1, 2024, 23:39 | Insight

Talha Badar: A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia

Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a post on X/Twitter: "A multicenter study of…

All: 1 Posts: 1 - 100

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

'

NIVOPOSTOP (GORTEC 2018-01): A Phase III Trial of Adjuvant Nivolumab in High-Risk Resected Head and Neck Squamous Cell Carcinoma

'

Bianca Balti: The Supermodel’s Brave Battle with Ovarian Cancer

'

NCD Frontlines with Saunthari Somasundaram | A New OncoDaily Podcast – Coming Soon

'

ASCO 2025 for Trainees and Residents: Your Ultimate Guide to Success

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023